Cartesian TherapeuticsRNAC
13F holders, Q1 2024 (March 31)4holders
$0.62avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Cartesian Therapeutics Inc. (RNAC) in their 13F filings. The largest holders were WR Wealth Planners, LLC ($780), Farther Finance Advisors, LLC ($302) and Parallel Advisors, LLC ($65).
- Company
- Cartesian Therapeutics Inc.
- CUSIP
- 816212302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $1K |
| Exits | 0 | $0 |
Ownership 4 holders
| WR Wealth Planners, LLC | 0.00% | New | 1,200 | $780 |
| Farther Finance Advisors, LLC | 0.00% | New | 539 | $302 |
| Parallel Advisors, LLC | 0.00% | New | 100 | $65 |
| Avior Wealth Management, LLC | 0.00% | New | 16 | $10 |
"% of holder's portfolio" is RNAC's weight in each manager's 13F, not the share of Cartesian Therapeutics Inc. the manager owns.